| 发明名称 |
METHOD FOR TREATING A COMPLEMENT MEDIATED DISORDER CAUSED BY AN INFECTIOUS AGENT IN A PATIENT |
| 摘要 |
The present disclosure relates to, inter alia, a method of treating a complement mediated disorder caused by an infectious agents in a patient, comprising administering an effective amount of a C5 inhibitor, such as eculizumab or an eculizumab variant, to the patient. |
| 申请公布号 |
US2016168237(A1) |
申请公布日期 |
2016.06.16 |
| 申请号 |
US201514966921 |
申请日期 |
2015.12.11 |
| 申请人 |
Alexion Pharmaceuticals, Inc. |
发明人 |
Fontenot Darrell;Puffer Bridget;Andrien Bruce;Doyle Mittie;Tamburini Paul;Bedrosian Camille |
| 分类号 |
C07K16/18;A61K39/395 |
主分类号 |
C07K16/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating a complement mediated disorder caused by an infectious agent in a human patient comprising administering an effective amount of a polypeptide inhibitor of human complement C5 protein to the human patient. |
| 地址 |
Cheshire CT US |
